TTUHSC Research
HomeOSP

News and Announcements

AHA sets summer application deadlines

The AHA is accepting applications for research awards that will begin on January 1, 2015. Deadlines vary for affiliate and national programs and for certain awards. Please see our funding opportunities page for program details and deadlines.

Founders Affiliate - July 25

Great Rivers Affiliate - July 23

Greater Southeast - July 25

Midwest Affiliate - July 22

National - July 24

SouthWest Affiliate - July 22

Western States Affiliate - July 23

Mid-Atlantic Affiliate - no summer deadline


Defense Health Program Department of Defense Breast Cancer Research Program Funding Opportunities for FY 2014

 FY14 BCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.

Era of Hope Scholar Award – Letter of intent due August 1, 2014, Full application due on August 15, 2014

Independent, non-mentored investigators within 6 years of their last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of the application submission deadline

  • Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields.        
  • PIs should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.        
  • PIs should exhibit strong potential for leadership in the breast cancer community
  • PIs must include breast cancer advocates on their research team.
  • Maximum funding of $2.5M for direct costs (plus indirect costs)
  • Period of performance not to exceed 5 years
Innovator Award – Nomination due May 14, 2014, Invited applications due August 15, 2014

Associate Professor or above (or equivalent)

  • Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.        
  • Provides opportunity to pursue novel, visionary, high-risk ideas that will accelerate progress toward ending breast cancer.        
  • PIs must include breast cancer advocates on their research team.
  • Nomination is required; self-nominations are accepted; application submission is by invitation only.
  • Maximum funding of $5M for direct costs (plus indirect costs)
  • Period of performance not to exceed 5 years
Breakthrough Award – Letter of intent is due May 14, 2014, Full applications due May 28, 2014

Investigators at all academic levels (or equivalent) / Postdoctoral fellows are eligible to apply

  • Supports promising research that has the potential to lead to or make breakthroughs in breast cancer.        
  • Potential impact of the research may be near-term or long-term, but it must be significant and go beyond an incremental advancement.        
  • Partnering PI Option allows two PIs, termed Initiating and Partnering PIs, to collaborate on a single application.        
  • Four different funding levels, based on the scope of research, are available. It is the responsibility of the PI to select the funding level that is most appropriate for the research proposed.

Funding Levels 1 and 2

  • Submission of a Letter of Intent is required prior to full application submission.        
  • Each PI may submit only one application as a single PI or Initiating PI.        
  • Breast cancer advocate involvement is encouraged, but not required.

 Funding Levels 3 and 4

  • Submission of a preproposal is required; application submission is by invitation only.        
  • Clinical trials are allowed.
  • Applicants must include breast cancer advocates on their research team.
  • Applications may be submitted under one of the following funding levels:

 Funding Level 1:

  • Maximum funding of $350,000 for direct costs (plus indirect costs)        
  • Period of performance not to exceed 3 years

Funding Level 2:

  • Maximum funding of $700,000 for direct costs (plus indirect costs)        
  • Period of performance not to exceed 3 years

Funding Level 3:

  • Maximum funding of $2.5M for direct costs (plus indirect costs)        
  • Period of performance not to exceed 5 years

Funding Level 4:

  • Maximum funding of $10M for direct costs (plus indirect costs)
  • Period of performance not to exceed 5 years

All applications must conform to the final Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website. The application packages containing the required forms for each award mechanism are also found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government's single-entry portal, Grants.gov. For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website

Point of Contact:

301-682-5507
help@ebrap.org


Vilcek Prizes For Creative Promise in Biomedical Science

The Vilcek Foundation will award three prizes of $50,000 each to young foreign-born biomedical scientists who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science. 


 Receive Customized NIH Guide Listings via Email

Do you find yourself repeating the same NIH Guide search over and over again looking for funding opportunity announcements?  If the answer is yes, then we have a new tool you are sure to love. The NIH Guide for Grants and Contracts now allows you to be notified when new NIH Guide postings match your search criteria. To get started, visit grants.nih.gov and perform your search, then from the Results page click "Save Your Search" to sign up for alerts based on that search criteria. The system can email you with new funding opportunity announcements and/or notices related to your search on a daily, weekly or monthly basis (your choice!).


NIH FY 2014 Fiscal Policy and Salary Cap

In a blog posting on February 14, 2014 by Dr. Sally Rockey, NIH Deputy Director for Extramural Research, provided additional details and context on the recently announced FY 2014 NIH Fiscal Policy and related announcements on salary cap and stipend


 NIH to Require Use of Updated Electronic Application Forms for Due Dates on or after September 25, 2013

 NIH is transitioning to updated electronic application forms packages. The new packages will be identified with a Competition ID of FORMS-C and will include the form changes documented at: http://grants.nih.gov/grants/ElectronicReceipt/files/FORMS-C_Changes.pdf.

For due dates on or after September 25, 2013, all applicants will be required to use FORMS-C packages, with some exceptions noted at in NIH Notice NOT-OD-13-074.  The requirement includes electronic applications submitted under the continuous submission policy, administrative supplement requests (Type 3), change of organization requests (Type 6) and change of grantee/training institution requests (Type 7) submitted September 25, 2013 and beyond. Multi-project applications that are transitioning to electronic submission beginning with the September 25, 2013 due dates (see NOT-OD-13-075) will also use FORMS-C packages. 


 NIH Public Access Policy

The NIH Public Access Policy ensures that the public has access to the published results of NIH funded research. It requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital archive PubMed Central immediately upon acceptance for publication. To help advance science and improve human health, the Policy requires that these papers are accessible to the public on PubMed Central no later than 12 months after publication.  Click here for more information: NIH Public Access page.

©